✦ LIBER ✦

Cardiovascular safety and glycemic control of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus: A pairwise and network meta-analysis

✍ Scribed by Sun, Feng; Yu, Kai; Wu, Shanshan; Zhang, Yuan; Yang, Zhirong; Shi, Luwen; Ji, Linong; Zhan, Siyan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glucagon-Like Peptide-1 Receptor Agonist

✍ Smilowitz, N. R.; Donnino, R.; Schwartzbard, A. 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 534 KB

Glucagon-like peptide-1 receptor agonist

✍ Y. Wang; L. Li; M. Yang; H. Liu; G. Boden; G. Yang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 692 KB

Efficacy and Safety of Long-Acting Gluca

✍ Pinelli, N. R.; Hurren, K. M. 📂 Article 📅 2011 🏛 Harvey Whitney Books Company 🌐 English ⚖ 278 KB

Glucagon-like peptide-1 receptor agonist

✍ Lund, Asger; Knop, Filip K.; Vilsbøll, Tina 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 484 KB

Glucagon-like peptide-1 receptor agonist

✍ Eng, Conrad (author);Kramer, Caroline K. (author);Zinman, Bernard (author);Retna 📂 Article 📅 2014 🏛 Lancet Publishing Group 🌐 English ⚖ 358 KB

Glucagon-like peptide-1 receptor agonist

✍ Eng, Conrad (author);Kramer, Caroline K. (author);Zinman, Bernard (author);Retna 📂 Article 📅 2014 🏛 Lancet Publishing Group 🌐 English ⚖ 358 KB